<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[joseph ramelli Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/joseph+ramelli.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to joseph ramelli]]></description>
	<s:counts start="0" returned="6" found="6" />
	<language>en-us</language>
	<item>
		<title><![CDATA[China Wind Systems: Poised for More Growth]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F168327-china-wind-systems-poised-for-more-growth%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Joseph Ramelli submits: China Wind Systems (CWSI.OB) recently completed a reverse stock split, which was the final step in preparing for a near term move to the Nasdaq. When we first invested in the company, I think that some people questioned whether a company with its roots in the garment...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 22 Oct 2009 02:07:30 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/energy.html"><![CDATA[Energy]]></category>
		<category domain="http://resources.bnet.com/topic/joseph+ramelli.html"><![CDATA[Joseph Ramelli]]></category>
		<category domain="http://resources.bnet.com/topic/general+electric+co..html"><![CDATA[General Electric Co.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GE</category>
		<category domain="tickers">GE</category>
	</item>
	<item>
		<title><![CDATA[Emisphere: The Most Undervalued Biotech]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F164094-emisphere-the-most-undervalued-biotech%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Joseph Ramelli submits: The FDA's clinicaltrials.gov website has some really interesting information on the European Phase III trial of Emisphere&#8217;s EMIS Oral Salmon Calcitonin for Osteoarthritis that is being run by Nordic Bioscience for Emisphere&#8217;s partner, Novartis NVS.         One of the Primary...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Wed, 30 Sep 2009 06:35:19 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/joseph+ramelli.html"><![CDATA[Joseph Ramelli]]></category>
		<category domain="http://resources.bnet.com/topic/emisphere+technologies+inc..html"><![CDATA[Emisphere Technologies Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EMIS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="tickers">EMIS,NVS</category>
	</item>
	<item>
		<title><![CDATA[The Emisphere Story Just Got Bigger]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F146402-the-emisphere-story-just-got-bigger%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Joseph Ramelli submits: There has been a huge positive development in the Emisphere story that hasn&#8217;t really filtered out yet. A friend stumbled upon a patent application filed by Novartis NVS entitled &#8220;Use of Calcitonin for the Treatment of Rheumatoid Arthritis.&#8221; The patent application can be viewed here.  The...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Wed, 01 Jul 2009 03:06:32 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/joseph+ramelli.html"><![CDATA[Joseph Ramelli]]></category>
		<category domain="http://resources.bnet.com/topic/emisphere+technologies+inc..html"><![CDATA[Emisphere Technologies Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EMIS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="tickers">EMIS,NVS</category>
	</item>
	<item>
		<title><![CDATA[Emisphere: Why We're Confident]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F137985-emisphere-why-we-re-confident%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Joseph Ramelli submits: We recently finished buying a position in Emisphere EMIS.  We have done a ton of due diligence and networked with some of the smartest biotech minds on the street and think that the stock should be trading at $5 now and that it will be well...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Sun, 17 May 2009 03:10:01 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/joseph+ramelli.html"><![CDATA[Joseph Ramelli]]></category>
		<category domain="http://resources.bnet.com/topic/emisphere+technologies+inc..html"><![CDATA[Emisphere Technologies Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EMIS</category>
		<category domain="tickers">EMIS</category>
	</item>
	<item>
		<title><![CDATA[BroadVision Handing Out Free Money]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F127952-broadvision-handing-out-free-money%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Joseph Ramelli submits:    In my last article I spoke of why we are so excited about one of our holdings, Linktone LTON. They announced a great quarter, highlighted by a return to profitability (not bad for a company that at the time was trading at ½ of...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 26 Mar 2009 03:22:01 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/internet.html"><![CDATA[Internet]]></category>
		<category domain="http://resources.bnet.com/topic/joseph+ramelli.html"><![CDATA[Joseph Ramelli]]></category>
	</item>
	<item>
		<title><![CDATA[The 'Link' to a Great Investment Idea]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F124292-the-link-to-a-great-investment-idea%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Joseph Ramelli submits: We recently finished acquiring a new  position in Linktone LTON.  The investment has a huge margin of safety  because the company is trading at half of its cash value ($104mm cash  and only a $51mm market cap), and has significant upside potential because...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 05 Mar 2009 04:18:01 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/china.html"><![CDATA[China]]></category>
		<category domain="http://resources.bnet.com/topic/joseph+ramelli.html"><![CDATA[Joseph Ramelli]]></category>
		<category domain="http://resources.bnet.com/topic/linktone.html"><![CDATA[Linktone]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LTON</category>
		<category domain="tickers">LTON</category>
	</item>
</channel>
</rss>
